Seven tesla field strength is a different category of procurement than anything else in the MRI market. The Terra's siting requirements are not merely more demanding than a 3T system; they are in a different order of magnitude. The 5-Gauss fringe field radius of a 7T magnet typically necessitates a purpose-built shielded enclosure, substantial floor load engineering, dedicated cryogenic infrastructure, and a building design that incorporates the magnetic environment from the foundation planning stage. For academic medical centers, research universities, and specialty neuroscience institutes, the Terra financing project is a multi-million-dollar capital commitment that spans years of planning before the first scan.
We finance Terra acquisitions for institutions that have completed the facility planning phase and are ready to secure the capital commitment alongside the equipment contract. Our role is not to advise on the facility design; that belongs to your facilities team and Siemens' site planning engineers. Our role is to structure a financing package that covers the magnet, the dedicated 7T-rated RF shielding enclosure, and the cryogenic and chiller infrastructure as a single coherent transaction with a timeline aligned to your construction milestones.
7T Terra: Siting, Infrastructure, and Financing Scope
The Magnetom Terra is the first 7T MRI system cleared by the FDA for clinical use in neuro and musculoskeletal applications, a regulatory milestone that distinguishes it from pure research platforms. Clinical clearance expands the potential funding sources for a Terra project because the system can generate scan revenue, not just grant-supported research output. For institutions building a business case around both research productivity and clinical revenue, that distinction matters to both the institutional capital planning committee and to the financing structure.
Siting a 7T magnet involves coordinating the construction schedule for the shielded enclosure, the helium handling systems, cold head and compressor infrastructure, and the RF and gradient electronics installation with Siemens' field service team. These interdependencies make the financing timeline more complex than a standard MRI project: funding needs to be available for construction draws before the magnet arrives, and the acceptance testing phase before clinical activation can extend the period between initial disbursement and first revenue. We structure Terra financings with milestone-based disbursement schedules that match these realities.
Institutions That Finance the Terra
Academic medical centers combining clinical operations with funded research programs represent the primary Terra buyer. The system's dual FDA-clearance-plus-research-tool identity makes it fundable through both clinical capital budgets and research infrastructure grants, and institutions that can layer those funding sources often find the effective financing cost of a Terra project lower than the sticker price suggests. Neuroscience institutes and specialized imaging research centers at major universities are the other significant cohort, though purely research deployments require more careful financial planning since they depend on grant renewal cycles rather than clinical scan revenue.
Research lab imaging programs at institutions with active NIH infrastructure or instrumentation grants should engage financing conversations in parallel with grant applications, because the timeline from grant award to equipment purchase often moves faster than institutions expect and being pre-positioned with a financing structure avoids delays. We work with grants and contracts offices that are managing these processes and understand the documentation requirements on both sides.
Financing Process for a 7T Acquisition
Terra projects require more documentation and a longer credit review than standard clinical MRI financings, reflecting the scale and complexity of the transaction. Financial statements, institutional capital plan documentation, and the facility engineering scope are all part of the underwriting package. For institutional borrowers, the review typically takes several days rather than 24 hours, and coordinating with the institution's legal and procurement teams adds time to the overall process. We are experienced with institutional procurement and understand the approval chains involved.
The financing structure for a Terra typically involves a long-term loan or capital lease with milestone-based funding disbursements tied to construction completion, magnet delivery, and system acceptance testing. A loan structure with ownership is common for institutions that want the Terra on the balance sheet as a capital asset. Those evaluating a lease structure should understand that the resale market for 7T systems is thin, which affects lease residual calculations differently than for more common clinical systems.
Other High-Field Siemens Systems
Institutions evaluating the Terra against 3T alternatives should look carefully at the Magnetom Vida, which provides the highest clinical 3T performance and research software options at a substantially lower project cost. For many research applications outside of ultra-high-field neuroimaging and spectroscopy, the Vida delivers comparable scientific value at a fraction of the Terra's total infrastructure investment. The right answer depends on the specific research or clinical protocols driving the acquisition decision, and we are available to discuss the financing implications of both paths.
Terra 7T Financing Questions
Discuss Terra 7T Financing
Ultra-high-field MRI financing for academic medical centers and neuroscience institutes. Milestone-based disbursement structures available. We work with institutional procurement and legal teams. Contact us to discuss the full project scope and financing structure.